Changes in the scope and intent of US state legislation on ivermectin and pharmacy dispensing trends, 2020–2026
by Dr. Jessica Ibiebele, Danielle Parchure, Tianci Chen, Dr. Veronika Wirtz, Dr. Kayoko Shioda, & […]
Research Cores
Infectious Disease Modeling Group
The BU Infectious Disease Modeling Group brings together students, faculty, and researchers from across the university who share an interest in infectious disease modeling and quantitative methods. The group is building a strong, collaborative infectious disease modeling community at BU by creating opportunities to connect, exchange technical expertise, develop new ideas, and support one another’s research.
In The Media
Publication Highlights
Events
Research on Tap: Sustaining Equitable Global Health Partnerships with Low- and Middle-Income Countries
Center News
Annual Report 2026
Read for an overview of CEID’s highlights from the 2025-2026 academic year.
BEACON to Monitor Disease Events at the 2026 FIFA World Cup
The FIFA World Cup 2026 (FWC 2026) officially kicks off on June 11, marking a historic tournament as it is hosted across three nations: Canada, the United States, and Mexico. While the World Cup brings immense excitement and shared celebration, major international mass gatherings like this also present unique public health challenges. When millions of […]
Celebrating One Year of BEACON
Happy Birthday to BEACON! It has been exactly one year since we celebrated the official launch of BEACON. In the world of public health and AI, a year can feel like a decade—and looking back at what this program has accomplished since April 2025, it’s clear we haven't just been "watching" the news; we’ve been […]
2026 Student/Trainee Summer Research Grant Opportunity
Boston University's Center on Emerging Infectious Diseases (CEID) is pleased to announce the availability of two research grants to students pursuing innovative research projects related to CEID’s mission. Open to students at the undergraduate level through the postdoctoral level, the project has to focus on public health, policy, clinical, social sciences, or data sciences […]
Virus Intelligence & Strategic Threat Assessment: New global collaboration uses experts and AI to spot the next pandemic
OSLO, SEP 4 —Global health and pandemic experts are banding together to combine their AI programmes and infectious disease knowledge to more accurately rank the viruses that have the potential to cause the next deadly pandemic. The new partnership will see the Coalition for Epidemic Preparedness Innovations (CEPI) and University of California, Davis (UC Davis) working […]
Annual Report 2025
Read for an overview of CEID's highlights from the 2024-2025 academic year.
Summer 2025 Updates
We hope everyone is enjoying a healthy and restful summer. Read on for the latest updates from CEID. Student Research Grants Congratulations to our two recipients of this year’s student/trainee research grants, Garima Kohli and Amy Zheng. These grants, $5,000 each, aim to support students in their academic and professional development by providing financial assistance for their research endeavors. […]
PRESS RELEASE – Infectious disease surveillance platform BEACON launches beta version as a new open-source global resource
APRIL 23, 2025FOR IMMEDIATE RELEASECONTACT:CASSANDRA KENNEDYMEDIA@BEACONBIO.ORG Infectious disease surveillance platform BEACON launches beta version as a new open-source global resource BOSTON, MA – The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate information on […]
Infectious Diseases At A Glance
33
%
of annual deaths worldwide are attributed to infectious diseases (Journal of Infection, 2023)
over half
of the world's population cannot obtain essential health services (World Health Organization, 2017)
60
%
of emerging infectious diseases that are reported globally are zoonoses (World Health Organization)
47
%
of the world's population have little to no access to diagnostics (The Lancet, 2021)